Announce Date | 02/12/2025 |
EPS Normalized Actual | $3.44 (Beat by $0.51) |
EPS GAAP Actual | $3.44 (Beat by $0.51) |
Revenue Actual | $5.072B |
Revenue Surprise | Beat by $5072M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 28.57 | 4.42 | 28.02409 | 29.81156 | 1 |
Dec 2028 | 25.45 | 4.97 | 24.96371 | 26.55598 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0 | 0 | 5.072B | -6.05% | 5072M |
FQ3 2024 (Sep 2024) | 7.12 | 7.12 | 5.122B | 1.09% | 5122M |
FQ2 2024 (Jun 2024) | 2.66 | 2.66 | 5.103B | 0.41% | 5103M |
FQ1 2024 (Mar 2024) | 21.6 | 21.6 | 5.368B | 6.46% | 5368M |
FQ4 2023 (Dec 2023) | 0.0078 | 0.0078 | 5.379B | 7.23% | 5379M |
FQ3 2023 (Sep 2023) | 0.99 | 0.99 | 5.066B | 5.23% | 5066M |
FQ2 2023 (Jun 2023) | 1.21 | 1.21 | 5.082B | 8.74% | 5082M |
FQ1 2023 (Mar 2023) | 2.89 | 2.89 | 5.021B | 100% | 5021M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.91 | -- | 3.70254 | 4.23983 | 4 |
FQ3 2027 (Sep 2027) | 3.47 | -- | 3.28589 | 3.76272 | 3 |
FQ2 2027 (Jun 2027) | 3.29 | -- | 3.11544 | 3.56753 | 4 |
FQ1 2027 (Mar 2027) | 3.64 | -- | 3.44687 | 3.94706 | 3 |
FQ4 2026 (Oct 2026) | 2.17697 | -- | 2.13105 | 2.22289 | 3 |
FQ3 2026 (Jul 2026) | 2.1524 | -- | 2.10699 | 2.19781 | 4 |
FQ2 2026 (Jun 2026) | 1.94002 | -- | 1.91439 | 1.96052 | 4 |
FQ1 2026 (Mar 2026) | 1.87751 | -- | 1.85271 | 1.89735 | 5 |
FQ4 2025 (Oct 2025) | 2.0661 | -- | 2.02251 | 2.10969 | 3 |
FQ3 2025 (Jul 2025) | 2.11197 | -237.13 | 2.06742 | 2.15652 | 3 |
FQ2 2025 (Jun 2025) | 1.71618 | -55 | 1.69351 | 1.73432 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 6.01B | -- | 5.76B | 6.4B | 5 |
FQ3 2027 (Sep 2027) | 5.76B | -- | 5.52B | 6.13B | 4 |
FQ2 2027 (Jun 2027) | 5.79B | -- | 5.56B | 6.17B | 5 |
FQ1 2027 (Mar 2027) | 5.66B | -- | 5.43B | 6.03B | 4 |
FQ4 2026 (Oct 2026) | 5.36B | -- | 5.28B | 5.45B | 4 |
FQ3 2026 (Jul 2026) | 5.47B | -- | 5.38B | 5.56B | 5 |
FQ2 2026 (Jun 2026) | 5.47B | -- | 5.41B | 5.51B | 5 |
FQ1 2026 (Mar 2026) | 5.46B | -- | 5.41B | 5.51B | 6 |
FQ4 2025 (Oct 2025) | 5.12B | 1.03 | 5.04B | 5.21B | 2 |
FQ3 2025 (Jul 2025) | 5.2B | 1.54 | 5.12B | 5.29B | 2 |
FQ2 2025 (Jun 2025) | 5.17B | 1.39 | 5.12B | 5.22B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 7.12 | 7.12 | 100% | |
FQ2 2024 (Jun 2024) | 2.66 | 2.66 | 100% | |
FQ1 2024 (Mar 2024) | 21.6 | 21.6 | 100% | |
FQ4 2023 (Dec 2023) | 0.0078 | 0.0078 | 100% | |
FQ3 2023 (Sep 2023) | 0.99 | 0.99 | 100% | |
FQ2 2023 (Jun 2023) | 1.21 | 1.21 | 100% | |
FQ1 2023 (Mar 2023) | 2.89 | 2.89 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $5.07B | $5072M | 100% |
FQ3 2024 (Sep 2024) | $0B | $5.12B | $5122M | 100% |
FQ2 2024 (Jun 2024) | $0B | $5.1B | $5103M | 100% |
FQ1 2024 (Mar 2024) | $0B | $5.37B | $5368M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.38B | $5379M | 100% |
FQ3 2023 (Sep 2023) | $0B | $5.07B | $5066M | 100% |
FQ2 2023 (Jun 2023) | $0B | $5.08B | $5082M | 100% |
FQ1 2023 (Mar 2023) | $0B | $5.02B | $5021M | 100% |